4//SEC Filing
WHOLIHAN EDWARD 4
Accession 0001209191-18-029082
CIK 0001624658other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 11:27 AM ET
Size
7.0 KB
Accession
0001209191-18-029082
Insider Transaction Report
Form 4
WHOLIHAN EDWARD
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-05-09$1.59/sh+25,000$39,750→ 25,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-09−25,000→ 167,031 totalExercise: $1.59Exp: 2026-09-15→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of the shares vested on June 20, 2017 and the remaining shares vest in 36 equal monthly installments thereafter
Documents
Issuer
Allena Pharmaceuticals, Inc.
CIK 0001624658
Entity typeother
Related Parties
1- filerCIK 0001719764
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 11:27 AM ET
- Size
- 7.0 KB